Companies from Roche Holding AG to Nissan Motor Co. have backpedaled on DEI policies in the US. But the Swiss drug maker says ...
LÜNEBURG, GERMANY AND BOSTON, MA / ACCESS Newswire / March 17, 2025 / Körber welcomes eschbach as the first partner in the ...
GlobalData on MSN17h
Scholar Rock SMA drug shows muscle function benefitScholar Rock’s spinal muscular atrophy (SMA) therapy has shown benefit in muscle function in children under 12 in a pivotal ...
The Munich-based Ifo Institute now expects Germany’s GDP to crawl ahead by just 0.2% in 2024, slashing its January forecast ...
DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, ...
A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some ...
Third Generation Sequencing Market 2025 BURLINGAME, CA, UNITED STATES, March 17, 2025 /EINPresswire / -- The Global Third Generation Sequencin ...
MANCHESTER UNITED are braced for a monumental summer transfer window – with Ruben Amorim expected to overhaul the squad with ...
VITRAKVI has strong market potential as a first-in-class TRK inhibitor for patients with NTRK gene fusion-positive cancers, regardless of tumor type. The growing adoption of precision oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback